| Literature DB >> 22837817 |
Alison B Duncan, Philip Agnew, Valérie Noel, Edith Demettre, Martial Seveno, Jean-Paul Brizard, Yannis Michalakis.
Abstract
Hosts are frequently infected with more than one parasite or pathogen at any one time, but little is known as to how they respond to multiple immune challenges compared to those involving single infections. We investigated the proteome of Aedes aegypti larvae following infection with either Edhazardia aedis or Vavraia culicis, and coinfections involving both. They are both obligate intracellular parasites belonging to the phylum microsporidia and infect natural populations of Ae. aegypti. The results found some proteins only showing modified abundance in response to infections involving E. aedis, while others were only differentially abundant when infections involved V. culicis. Some proteins only responded with modified abundance to the coinfection condition, while others were differentially abundant in response to all three types of infection. As time since infection increased, the response to each of the single parasite infections diverged, while the response to the E. aedis and coinfection treatments converged. Some of the proteins differentially abundant in response to infection were identified. They included two vacuolar ATPases, proteins known to have a role in determining the infection success of intracellular parasites. This result suggests microsporidia could influence the infection success of other intracellular pathogens infecting vector species of mosquito, including viruses, Plasmodium and Wolbachia.Entities:
Keywords: Aedes aegypti; Edhazardia aedis; Vavraia culicis; coinfection; dengue; proteome
Year: 2012 PMID: 22837817 PMCID: PMC3399191 DOI: 10.1002/ece3.199
Source DB: PubMed Journal: Ecol Evol ISSN: 2045-7758 Impact factor: 2.912
Figure 1The number of proteins with modified abundance and the treatment(s) in which they were found. The numbers indicate the number of proteins from infected larvae with spot abundance significantly lower (−) or higher (+) than for uninfected larvae sampled on the same day(s). (A) Proteins only showing modified abundance in five-day-old larvae. (B) Proteins only showing modified abundance in 15-day-old larvae. (C) Proteins with modified abundance in both five- and 15-day-old larvae. (D) The absolute number of proteins with modified abundance, including both days of sampling. The “VE” label is for the coinfection treatment involving both V. culicis and E. aedis, the “E” label is for the E. aedis only infection treatment, and the “V” label is for the V. culicis only infection treatment.
Figure 2A representative 2D electrophoresis Coomassie-stained gel for protein extracted from infected larvae (replicates comprised of 10 pooled larvae from each treatment, with 26 µg of sample loaded on to each gel). The spot numbers indicated correspond to the proteins identified in Table 1 with modified abundance in the infection treatments. Protein spots shown in red were upregulated, and those in blue downregulated, relative to the uninfected control. Infection treatments with differential protein abundance on the different sampling days are indicated as follows *the single V. culicis treatment on day 5; ∧ the single V. culicis and the single E. aedis treatments on day 5; ° the single V. culicis and the single E. aedis treatments on day 5 and day 15; $ the single E. eadis treatment on day 15 and the coinfection treatment on day 15; and # the coinfection treatment on day 15 infection.
Proteins identified in this study.
| Spot | Protein name | Access number | MASCOT score | Theoretical mass | Theoretical pI | Sequence coverage (%) | Peptide number | Day(s) | Treatment(s) involved | Spot volume |
|---|---|---|---|---|---|---|---|---|---|---|
| 120 | Ferritin heavy chain-like protein | Q8T4R8_AEDAE | 78 | 23,802 | 5.64 | 33 | 8 | 5 | E, V | - |
| 157 | Catalase | Q1HRH7_AEDAE | 92 | 48,836 | 7.28 | 27 | 10 | 5 | V | - |
| 265 | Catalase | Q1HRH7_AEDAE | 100 | 48,836 | 7.28 | 26 | 10 | 5 | E, V | - |
| 438 | Catalase | Q1HRH7_AEDAE | 88 | 48,836 | 7.28 | 24 | 9 | 5 | V | - |
| 9 | Actin | Q17KG3_AEDAE | 127 | 42,148.9 | 5.22 | 39 | 15 | 15 | E, VE | + |
| 29 | Actin | Q17KG3_AEDAE | 60 | 42,148.9 | 5.22 | 23 | 11 | 5 | E, V | - |
| 74 | Actin | Q17KG3_AEDAE | 53 | 42,148.9 | 5.22 | 21 | 8 | 5 | V | - |
| 115 | Actin | Q178B0_AEDAE | 67 | 41918.8 | 5.29 | 20 | 9 | 15 | E, VE | - |
| 120 | Vacuolar ATPase B subunit | Q9XYC8_AEDAE | 96 | 55,466.3 | 5.38 | 27 | 10 | 5 | E, V | - |
| 175 | Enolase | Q17KK5_AEDAE | 51 | 46,877.1 | 6.28 | 21 | 9 | 5 and 15 | E, V | - |
| 324 | Enolase | Q17KK5_AEDAE | 161 | 46,877.1 | 6.28 | 44 | 19 | 5 | V | - |
| 324 | Enolase | Q17KK5_AEDAE | 104 | 46,877.1 | 6.28 | 30 | 10 | 5 | V | - |
| 234 | V-type proton ATPase catalytic subunit A | VATA_AEDAE | 52 | 68,527.6 | 5.26 | 11 | 6 | 5 | E, V | - |
| 131 | Glutathione S-transferase | Q16P79_AEDAE | 149 | 27,034 | 5.24 | 50 | 16 | 5 | V | - |
| 135 | Arginine or creatine kinase | Q1HR67_AEDAE | 152 | 40,191 | 5.97 | 38 | 14 | 5 and 15 | VE | + |
| 208 | Arginine or creatine kinase | Q1HR67_AEDAE | 78 | 40,191 | 5.97 | 30 | 9 | 5 | V | - |
| 35 | — | Q17G18_AEDAE | 165 | 23,677 | 4.71 | 46 | 13 | 5 | E, V | - |
| 181 | — | Q16YP3_AEDAE | 84 | 29,644 | 4.89 | 35 | 8 | 5 | E, V | - |
“Access number” refers to accession number in SwissProt and TrEMBL protein databases.
“MASCOT scores” > 50 indicate extensive homology while those > 68 indicate significant identity (P < 0.05).
V, V. culicis only; E, E. aedis only; VE, coinfection with V. culicis and E. aedis.
Spot volume relative to uninfected larvae on same day(s) of sampling; + = higher, − = lower.
Spot 120 was assigned two possible identities.
Summary of infection levels for V. culicis and E. aedis in all treatment groups where infection could be confirmed.
| Single | Mixed infection | Single | Mixed infection | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No hypoxia | Hypoxia | No hypoxia | Hypoxia | No hypoxia | Hypoxia | No hypoxia | Hypoxia | ||||||||||
| Day 5 | Day 15 | Day 5 | Day 15 | Day 5 | Day 15 | Day 5 | Day 15 | Day 5 | Day 15 | Day 5 | Day 15 | Day 5 | Day 15 | Day 5 | Day 15 | ||
| Proportion infected, (± CI) | - | 94%, (−0.814, +0.984) | - | 72%, (−0.573, +0.832) | - | 86%, (−0.713, +0.939) | - | 0.57, (−0.422, +0.709) | 86%, (0.706, +0.937) | 86%, (−0.713, +0.939) | 89%, (−0.740, +0.955) | 88%, (−0.750, +0.948) | 91%, (−0.787, +0.972) | 87%, (−0.711, 0.972) | 89%, (−0.759, +0.958) | 88%, (−0.700, +0.958) | |
Summary of protein spots with abundance profiles affected by experimental treatments, but not included in analyses as differences are not attributable to infection treatments, or did not show clear patterns in the change of abundance.
| Sampling day only | Hypoxia alone, or combined with sampling day or parasite treatment | Influence of parasite treatment | Combined influence of infection and sampling day | |
|---|---|---|---|---|
| Number of spots | 176 | 51 | 8 | 13 |
| Reason excluded | Differences in abundance profiles unrelated to infection treatments. | Abundance depends on stress induced by hypoxia treatment, and not directly on presence of infection. | Differences in abundance expression profiles could not be detected between infected and uninfected larvae (e.g., spot volume was different between two parasite treatments, but neither was different from uninfected larvae). | Heterogeneous patterns of abundance on the two sampling days (e.g., increased volume on day 5 in response to infection with |
| Observations and remarks | Spots sampled on day 15 were larger than spots sampled on day 5. | Spots from day 5 tended to be smaller. | Although these proteins may be active in the response to infection, their exclusion avoids overinterpretation of abundance. |